Description

Oliveira et al reported revised criteria for the diagnosis of the autoimmune lymphoproliferative syndrome (ALPS). The criteria were developed at a 2009 NIH International Workshop.


 

Criteria:

(1) required

(2) primary accessory

(3) secondary accessory

 

Required:

(1) one or both of the following:

(1a) chronic nonmalignant, noninfectious lymphadenopathy

(1b) chronic nonmalignant, noninfectious splenomegaly

(2) both of the following:

(2a) elevated CD3+TCR(alpha,beta)+CD4-CD8- double negative T cells

(2b) normal or elevated lymphocyte count

 

where:

• Chronic indicates > 6 months.

• Elevated double negative T cells: >= 1.5% of total lymphocyte count OR >= 2.5% of CD3+ lymphocytes.

 

Primary accessory:

(1) defective lymphocyte apoptosis (in 2 separate assays)

(2) somatic or germline pathogenic mutation in CASP10, FAS or FAS ligand

 

Secondary accessory:

(1) elevated plasma soluble FAS ligand concentration

(2) elevated plasma or serum vitamin B12 concentration

(3) elevated plasma IL-10 concentration

(4) elevated plasma IL-18 concentration

(5) typical immunohistological findings confirmed by an experienced hematopathologist

(6) >= 1 autoimmune cytopenia (anemia, thrombocytopenia, neutropenia) AND elevated polyclonal IgG concentration (polyclonal hypergammaglobulinemia)

(7) family history of a nonmalignant or noninfectious lymphoproliferation with or without autoimmunity

Required

Primary Accessory

Secondary Accessory

Diagnosis

both

>= 1

NA

definitive

both

NA

>= 1

probable

 


To read more or access our algorithms and calculators, please log in or register.